Filana Therapeutics (FLNA) vs Lite Strategy (LITS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lite Strategy (LITS) has outperformed Filana Therapeutics (FLNA) over the past year, losing 48.2% versus a loss of 76.1%. Over five years, LITS leads with a -97.8% price change compared with -98.4% for FLNA. Lite Strategy is the larger company by market cap ($38.0 million vs $37.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLNA | LITS |
|---|---|---|
| Share price | $0.7832 | $1.25 |
| Market cap | $37.83M | $38.01M |
| 1-day change | -3.98% | -1.59% |
| YTD return | -58.80% | -3.79% |
| 1-year return | -76.15% | -48.16% |
| 5-year return | -98.36% | -97.82% |
| EPS (TTM) | $-0.87 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $2.97 |
| 52-week low | $0.67 | $0.69 |
| Distance from 52-week high | -84.27% | -57.92% |
| Average volume | 2.03M | 448.62K |
| Shares outstanding | 48.31M | 30.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LITS has outperformed FLNA by 28.0 percentage points over the past year.
FLNA vs LITS FAQ
Which is bigger, Filana Therapeutics or Lite Strategy?
Lite Strategy (LITS) is larger, with a market capitalization of $38.01M compared with $37.83M for Filana Therapeutics (FLNA).
Which stock has performed better over the past year, FLNA or LITS?
LITS returned -48.16% over the past 12 months, compared with -76.15% for FLNA (price return, excluding dividends). Past performance does not predict future results.
Are Filana Therapeutics and Lite Strategy in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.